Meet Our Team

Jason Ng

Founder & CEO

  • Jason Ng has over three decades of drug delivery device development and manufacturing leadership. His know-how leads to innovative products with lower development costs.
  • He has been an integral part of three corporations that successfully brought insulin pumps through FDA approval and commercialization
  • In his role as Vice President of Operations at Insulet Corp, Jason managed the global manufacturing operations and supported the company’s IPO effort 
  • At Nipro Diabetes (Japan), he served as Director of R&D for the external insulin pump program, achieving FDA approval 
  • Jason served as a Senior Engineer at MiniMed, playing a pivotal role in the team responsible for product development of the external insulin pump device. Notably, Medtronic later acquired MiniMed for $3.6 billion.

Dr. Michael (Yanhui) Ma

Co-Founder

  • Dr. Ma studied and conducted research at the University of California, San Francisco Medical School (UCSF), under the mentorship of esteemed professors in diabetes, Dr. Gerald Grodsky and Dr. John Karam
  • Dr. Ma has founded and co-founded companies in healthcare, education, and the environmental technology industry.
  • Dr. Ma has served on the board of directors for both private and publicly listed companies on the NYSE and NASDAQ
  • Dr. Ma is the chairman of the board of MedNovo, established in 2000 and based in Beijing, China
  • MedNovo specializes in the research, development, and manufacturing of insulin pumps. It is one of the main players in the Chinese diabetes market, with well-established distribution and marketing channels throughout the country.

Technical & Regulatory Team

Arthur Hermann
Marketing and Communications Consultant

Arthur has three decades of health technology experience, including 20 years at Kaiser Permanente. There he designed numerous systems to improve access and ease of use for clinicians and patients through innovative technologies.

Ruthann R. DePietro
Quality and Regulatory Advisor

Ruthann DePietro is a seasoned senior executive with over three decades of leadership in the Medical Device and In-vitro Diagnostic (VD) industries. With a career spanning global regulatory strategies, systems, and clinical affairs.

Ruthann has been recognized for introducing risk management cultures within all aspects of the business, leading complex product and system development and improvements, and aligning regulatory strategy with business growth.

She served as Vice President of Quality, Regulatory, and Clinical Affairs at Instrumentation Laboratory Company, a Werfen Company, where she led global compliance initiatives and regulatory strategies across Manufacturing multiple sites in the U.S. and Europe. 

Vice President of Quality and Regulatory at Insulet Corporation. Where she played a key role in establishing risk-based quality systems and managing regulatory submissions, globally

Arthur Hermann
Marketing and Communications Consultant

Arthur has three decades of health technology experience, including 20 years at Kaiser Permanente. There he designed numerous systems to improve access and ease of use for clinicians and patients through innovative technologies.

Ruthann R. DePietro
Quality and Regulatory Advisor

Ruthann DePietro is a seasoned senior executive with over three decades of leadership in the Medical Device and In-vitro Diagnostic (VD) industries. With a career spanning global regulatory strategies, systems, and clinical affairs.

Ruthann has been recognized for introducing risk management cultures within all aspects of the business, leading complex product and system development and improvements, and aligning regulatory strategy with business growth.

She served as Vice President of Quality, Regulatory, and Clinical Affairs at Instrumentation Laboratory Company, a Werfen Company, where she led global compliance initiatives and regulatory strategies across Manufacturing multiple sites in the U.S. and Europe. 

Vice President of Quality and Regulatory at Insulet Corporation. Where she played a key role in establishing risk-based quality systems and managing regulatory submissions, globally